The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Progress in the understanding of the protein C anticoagulant pathway.

På svenska

Author

Summary, in English

A natural anticoagulant pathway denoted the protein C system provides specific and efficient control of blood coagulation. Protein C is the key component of the system and circulates in the blood as a zymogen to an anticoagulant serine protease.Activation of protein C is achieved on the surface of endothelial cells by thrombin bound to the membrane protein thrombomodulin. The endothelial protein C receptor stimulates the activation of protein C on the endothelium. Activated protein C (APC) modulates blood coagulation by cleaving a limited number of peptide bonds in factor VIIIa (FVIIIa) and factor Va (FVa), cofactors in the activation of factor X and prothrombin, respectively.Vitamin K-dependent protein S stimulates the APC-mediated regulation of coagulation. Not only is protein S involved in the degradation of FVIIIa, but so is FV, which in recent years has been found to be a Janus-faced protein with both procoagulant and anticoagulant potentials.A number of genetic defects affecting the anticoagulant function of the protein C system, eg,APC resistance (Arg506Gln or FV Leiden) and deficiencies of protein C and protein S constitute major risk factors of venous thrombosis.The protein C system also has anti-inflammatory and antiapoptotic potentials,the molecular mechanisms of which are beginning to be unraveled.APC has emerged in recent years as a useful therapeutic compound in the treatment of severe septic shock.The beneficial effect of APC is believed be due to both its anticoagulant and its anti-inflammatory properties.

Publishing year

2004

Language

English

Pages

109-116

Publication/Series

International Journal of Hematology

Volume

79

Issue

2

Document type

Journal article

Publisher

Springer

Topic

  • Medicinal Chemistry

Status

Published

Research group

  • Clinical Chemistry, Malmö

ISBN/ISSN/Other

  • ISSN: 0925-5710